# Post Market Clinical Follow-Up Study for EVOLUTION® NitrX™ Keeled Tibia and EVOLUTION® NitrX™ CS/CR Femur With Cruciate Sacrificing Insert

> **NCT04816773** · — · ENROLLING_BY_INVITATION · sponsor: **MicroPort Orthopedics Inc.** · enrollment: 150 (estimated)

## Conditions studied

- Joint Diseases
- Osteoarthritis
- Arthritis Knee
- Avascular Necrosis

## Interventions

- **DEVICE:** EVOLUTION® NitrX™

## Key facts

- **NCT ID:** NCT04816773
- **Lead sponsor:** MicroPort Orthopedics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2022-01-27
- **Primary completion:** 2034-08
- **Final completion:** 2035-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2024-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04816773

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04816773, "Post Market Clinical Follow-Up Study for EVOLUTION® NitrX™ Keeled Tibia and EVOLUTION® NitrX™ CS/CR Femur With Cruciate Sacrificing Insert". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04816773. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*